Allianz SE (ALVG.DE)
ALVG.DE on Xetra
191.50EUR
18 May 2018
191.50EUR
18 May 2018
Change (% chg)
€-0.30 (-0.16%)
€-0.30 (-0.16%)
Prev Close
€191.80
€191.80
Open
€191.90
€191.90
Day's High
€192.82
€192.82
Day's Low
€190.66
€190.66
Volume
1,755,359
1,755,359
Avg. Vol
1,462,504
1,462,504
52-wk High
€206.85
€206.85
52-wk Low
€169.35
€169.35
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 4.38 | December | 19 May 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 8 | 8 | 8 | 7 |
| (2) OUTPERFORM | 6 | 6 | 8 | 7 |
| (3) HOLD | 18 | 18 | 16 | 16 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 3 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.31 | 2.31 | 2.25 | 2.45 |
Consensus Estimates Analysis
Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 1 | 30,324.50 | 30,324.50 | 30,324.50 | -- |
| Quarter Ending Sep-18 | 1 | 30,324.50 | 30,324.50 | 30,324.50 | -- |
| Year Ending Dec-18 | 14 | 119,743.00 | 130,227.00 | 100,000.00 | 116,001.00 |
| Year Ending Dec-19 | 14 | 123,666.00 | 135,032.00 | 106,913.00 | 118,748.00 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 4 | 4.38 | 4.92 | 4.02 | 4.90 |
| Quarter Ending Sep-18 | 4 | 4.39 | 4.57 | 4.00 | 3.99 |
| Year Ending Dec-18 | 27 | 17.34 | 18.41 | 15.80 | 16.44 |
| Year Ending Dec-19 | 27 | 18.38 | 19.61 | 15.23 | 16.97 |
| LT Growth Rate (%) | 4 | 8.45 | 9.76 | 7.40 | 5.18 |
Historical Surprises
Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-18 | 34,548.40 | 36,478.00 | 1,929.64 | 5.59 |
| Quarter Ending Dec-17 | 30,961.60 | 31,676.00 | 714.42 | 2.31 |
| Quarter Ending Sep-17 | 27,505.30 | 28,256.00 | 750.71 | 2.73 |
| Quarter Ending Jun-17 | 29,711.30 | 29,994.00 | 282.68 | 0.95 |
| Quarter Ending Mar-17 | 35,358.50 | 36,224.00 | 865.47 | 2.45 |
| Earnings (per share) | ||||
| Quarter Ending Mar-18 | 4.44 | 4.40 | 0.04 | 0.81 |
| Quarter Ending Dec-17 | 3.79 | 3.24 | 0.55 | 14.55 |
| Quarter Ending Sep-17 | 3.67 | 3.52 | 0.15 | 3.97 |
| Quarter Ending Jun-17 | 4.08 | 4.55 | 0.47 | 11.55 |
| Quarter Ending Mar-17 | 3.94 | 4.47 | 0.53 | 13.52 |
Consensus Estimates Trend
Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 30,324.50 | 31,675.70 | 31,675.70 | 31,675.70 | -- |
| Quarter Ending Sep-18 | 30,324.50 | 31,675.70 | 31,675.70 | 31,675.70 | -- |
| Year Ending Dec-18 | 119,743.00 | 121,512.00 | 121,511.00 | 119,594.00 | 116,001.00 |
| Year Ending Dec-19 | 123,666.00 | 124,873.00 | 124,872.00 | 123,291.00 | 118,748.00 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 4.38 | 3.80 | 3.80 | 4.52 | 4.90 |
| Quarter Ending Sep-18 | 4.39 | 4.52 | 4.52 | 4.36 | 3.99 |
| Year Ending Dec-18 | 17.34 | 17.33 | 17.31 | 17.36 | 16.44 |
| Year Ending Dec-19 | 18.38 | 18.34 | 18.29 | 18.32 | 16.97 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-18 | 0 | 1 | 0 | 1 |
| Quarter Ending Sep-18 | 0 | 1 | 0 | 1 |
| Year Ending Dec-18 | 0 | 5 | 0 | 5 |
| Year Ending Dec-19 | 1 | 3 | 1 | 3 |
| Earnings | ||||
| Quarter Ending Jun-18 | 2 | 1 | 2 | 1 |
| Quarter Ending Sep-18 | 1 | 2 | 1 | 2 |
| Year Ending Dec-18 | 7 | 3 | 8 | 5 |
| Year Ending Dec-19 | 5 | 6 | 7 | 7 |
Earnings vs. 
Estimates